title: Cholesterol reduction in cyclosporine-treated renal transplant patients: effect on platelet-derived growth factor levels and platelet activation.
authors.affiliation: Section of Nephrology, University of Manitoba, Winnipeg, Canada.
authors.forename: O
authors.initials: O
authors.lastname: Rigatto
authors.forename: D
authors.initials: D
authors.lastname: Rush
authors.forename: Y
authors.initials: Y
authors.lastname: Perry
authors.forename: S
authors.initials: S
authors.lastname: Walker
authors.forename: R
authors.initials: R
authors.lastname: Bose
authors.forename: P
authors.initials: P
authors.lastname: Bolli
mesh_terms: D001161:Arteriosclerosis / Q000097:blood / Q000139:chemically induced*; D002784:Cholesterol / Q000097:blood*; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects*; D015539:Platelet Activation / Q000187:drug effects; D010982:Platelet-Derived Growth Factor / Q000378:metabolism*; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D010982:Platelet-Derived Growth Factor; D016572:Cyclosporine; D002784:Cholesterol